Twist Bioscience
30.32
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Twist Bioscience
Twist Bioscience Corp is a pioneering synthetic biology company that has developed a groundbreaking DNA synthesis platform aimed at industrializing biological engineering. Utilizing a proprietary semiconductor-based process, the company synthesizes DNA on a silicon platform rather than the traditional plastic substrates, enabling faster and more cost-effective production of high-quality synthetic DNA. This innovative approach not only addresses inefficiencies but also facilitates rapid, high-throughput synthesis, empowering researchers to swiftly capitalize on future opportunities. Geographically, the majority of the company's revenue is generated in the United States.
Trade GPT
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.